Приказ основних података о документу

dc.creatorNedeljković, Nikola
dc.creatorNikolić, Miloš
dc.creatorČanović, Petar
dc.creatorZarić, Milan
dc.creatorŽivković-Zarić, Radica
dc.creatorBošković, Jelena
dc.creatorVesović, Marina
dc.creatorBradić, Jovana
dc.creatorAnđić, Marijana
dc.creatorKočović, Aleksandar
dc.creatorNikolić, Marina
dc.creatorJakovljević, Vladimir
dc.creatorVujić, Zorica
dc.creatorDobričić, Vladimir
dc.date.accessioned2024-01-17T08:04:22Z
dc.date.available2024-01-17T08:04:22Z
dc.date.issued2024
dc.identifier.issn1999-4923
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5449
dc.description.abstractThe objective of this study was to synthesize seven novel thiourea derivatives of naproxen (8–14), examine the anti-inflammatory activity of the newly synthesized compounds, investigate the cytotoxic potential of both sets of synthesized compounds (1–7 and 8–14), and select the most promising anti-inflammatory and antitumor drug candidates. The results of the in vivo anti-inflammatory study clearly showed that compounds 8 and 9 were capable of decreasing paw edema, as evident from a high percentage of inhibition (44.83% and 49.29%, respectively). In addition, the results of in vitro enzyme inhibition assays demonstrated that neither of the newly synthesized compounds reached 50% inhibition of 5-LOX at concentrations lower than 100 μM. In terms of antitumor potential, derivatives 3 and 8 exhibited strong cytotoxic effects on the HeLa cell line, suggesting the involvement of the extrinsic pathway of apoptosis. According to the overall results obtained for both sets of synthesized molecules, derivatives 4 and 8 can be underlined as molecules with the strongest anti-inflammatory activity, while derivatives 3 and 8 are the most promising cytotoxic agents.sr
dc.language.isoensr
dc.publisherMDPIsr
dc.relationinfo:eu-repo/grantAgreement/ScienceFundRS/Ideje/7739840/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200111/RS//sr
dc.relationFaculty of Medical Sciences, University of Kragujevac (Junior Project 11/20)sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourcePharmaceuticssr
dc.subjectnaproxensr
dc.subjectthioureasr
dc.subjectanti-inflammatory activitysr
dc.subjectpaw edemasr
dc.subjectcytotoxic activitysr
dc.subjectMTTsr
dc.subjectapoptosissr
dc.subjectCOX-2sr
dc.subject5-LOXsr
dc.titleSynthesis, Characterization, and Investigation of Anti-Inflammatory and Cytotoxic Activities of Novel Thiourea Derivatives of Naproxensr
dc.typearticlesr
dc.rights.licenseBYsr
dc.citation.volume16
dc.citation.issue1
dc.citation.spage1
dc.identifier.wos001151136100001
dc.identifier.doi10.3390/pharmaceutics16010001
dc.identifier.pmid38276479
dc.identifier.scopus2-s2.0-85183122869
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/15216/Synthesis_Characterization_and_pub_2024.pdf
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу